Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Faya

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Pharmaceutical Statistics|June 26, 2024
To Dilute or Not to Dilute: Nominal Titer Dosing for Genetic MedicinesPaul Faya, Tianhui Zhang
PDA Journal of Pharmaceutical Science and Technology|October 30, 2016
A Bayesian Approach to Determination of <i>F, D</i>, and <i>Z</i> Values Used in Steam Sterilization ValidationPaul Faya, James D Stamey, John W Seaman
Journal of Biopharmaceutical Statistics|September 22, 2024
Non-constant mean relative potency for antibody-dependent cellular cytotoxicity assaysPaul Faya, Tianhui Zhang, Wendy Walton, et al.
Pharmaceutical Statistics|November 26, 2025
Confidence Intervals for Validation of Analytical Procedures Under ICH Q2(R2)Paul Faya, Chad N Wolfe, Adam P Rauk
Journal of Biopharmaceutical Statistics|February 19, 2016
Bayesian assurance and sample size determination in the process validation life-cyclePaul Faya, John W Seaman, James D Stamey
Statistics in Medicine|May 17, 2018
Using accelerated drug stability results to inform long-term studies in shelf life determinationPaul Faya, John W Seaman, James D Stamey
Journal of Biopharmaceutical Statistics|March 13, 2020
A curve similarity approach to parallelism testing in bioassayPaul Faya, Adam P Rauk, Kristi L Griffiths, et al.
Journal of Pharmaceutical and Biomedical Analysis|September 5, 2020
Potency assignment of biotherapeutic reference standardsPaul Faya, Matthew W Borer, Kristi L Griffiths, et al.
Pharmaceutical Statistics|May 10, 2023
Stability analysis using mixed models: A critique of tolerance interval methods and a probabilistic solutionStan Altan, Paul Faya, Adam P Rauk, et al.
Pharmaceutical Statistics|October 7, 2020
The current state of Bayesian methods in nonclinical pharmaceutical statistics: Survey results and recommendations from the DIA/ASA-BIOP Nonclinical Bayesian Working GroupPaul Faya, Perceval Sondag, Steven Novick, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Pharmaceutical Statistics|June 26, 2024
To Dilute or Not to Dilute: Nominal Titer Dosing for Genetic MedicinesPaul Faya, Tianhui Zhang
PDA Journal of Pharmaceutical Science and Technology|October 30, 2016
A Bayesian Approach to Determination of <i>F, D</i>, and <i>Z</i> Values Used in Steam Sterilization ValidationPaul Faya, James D Stamey, John W Seaman
Journal of Biopharmaceutical Statistics|September 22, 2024
Non-constant mean relative potency for antibody-dependent cellular cytotoxicity assaysPaul Faya, Tianhui Zhang, Wendy Walton, et al.
Pharmaceutical Statistics|November 26, 2025
Confidence Intervals for Validation of Analytical Procedures Under ICH Q2(R2)Paul Faya, Chad N Wolfe, Adam P Rauk
Journal of Biopharmaceutical Statistics|February 19, 2016
Bayesian assurance and sample size determination in the process validation life-cyclePaul Faya, John W Seaman, James D Stamey
Statistics in Medicine|May 17, 2018
Using accelerated drug stability results to inform long-term studies in shelf life determinationPaul Faya, John W Seaman, James D Stamey
Journal of Biopharmaceutical Statistics|March 13, 2020
A curve similarity approach to parallelism testing in bioassayPaul Faya, Adam P Rauk, Kristi L Griffiths, et al.
Journal of Pharmaceutical and Biomedical Analysis|September 5, 2020
Potency assignment of biotherapeutic reference standardsPaul Faya, Matthew W Borer, Kristi L Griffiths, et al.
Pharmaceutical Statistics|May 10, 2023
Stability analysis using mixed models: A critique of tolerance interval methods and a probabilistic solutionStan Altan, Paul Faya, Adam P Rauk, et al.
Pharmaceutical Statistics|October 7, 2020
The current state of Bayesian methods in nonclinical pharmaceutical statistics: Survey results and recommendations from the DIA/ASA-BIOP Nonclinical Bayesian Working GroupPaul Faya, Perceval Sondag, Steven Novick, et al.
Pageof 2